Based on recent data, Ekso Bionics Holdings, Inc. (EKSO) shows an Average True Range (ATR) of 0.84 and an Enterprise Value of 19.66M. Its average trading volume over the past 3 months is 1.89M, indicating liquidity. These fundamental metrics provide insight into EKSO's underlying financial health and market activity.
Ekso Bionics Holdings, Inc. (EKSO) technical indicators as of December 31, 2025: the SMA 20 is 107%, SMA 50 at 116.25%, and SMA 200 at 122.1%. The RSI 14 value is 90.74, suggesting its current momentum. These technical analysis signals help assess EKSO's price trends and potential future movements.
Ekso Bionics Holdings, Inc. (EKSO) stock performance overview as of December 31, 2025: The 52-week high is $224.625 (currently -29.35% below), and the 52-week low is $2.73 (currently 287.55% above). Over the past year, EKSO's performance is -92.23%, compared to the S&P 500's 12.29% change.
According to market data, Ekso Bionics Holdings, Inc. (EKSO) stock's recent performance metrics show that over the last month, EKSO is 136.69%, with a Year-to-Date (YTD) performance of -92.29%. Over the past year, the stock has seen a -92.23% change. These figures summarize EKSO's price movements across various periods, reflecting its historical returns.
According to current financial data, EKSO stock's P/E (TTM) ratio is -1.39, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for EKSO, including P/S (0.99), P/B (1.50), and P/FCF (-1.64), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep